We serve Chemical Name:3-Methyl-2-quinoxalinecarboxylic acid CAS:74003-63-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-Methyl-2-quinoxalinecarboxylic acid
CAS.NO:74003-63-7
Synonyms:3-Methyl-quinoxaline-2-carboxylic acid;2-Methyl-3-carboxy-chinoxalin;3-Methylchinoxalin-2-carbonsaeure;methylquinoxalinecarboxylicacid;3-Methyl-2-quinoxalinecarboxylic acid;3-methylquinoxaline-2-carboxylic acid;2-Quinoxalinecarboxylic acid, 3-methyl-
Molecular Formula:C10H8N2O2
Molecular Weight:188.183
HS Code:2933990090
Physical and Chemical Properties:
Melting point:168-170ºC
Boiling point:347.1±37.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.673
PSA:63.08000
Exact Mass:188.058578
LogP:2.26
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like 3-Methyl-quinoxaline-2-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Quinoxalinecarboxylic acid, 3-methyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Methylchinoxalin-2-carbonsaeure Use and application,2-Methyl-3-carboxy-chinoxalin technical grade,usp/ep/jp grade.
Related News: “Alcami supported this product with supply constraints and successfully developed a capsule formulation for two dosage strengths,” she explains. “The formulations group performed studies at a micro-laboratory scale using a scientifically-based approach to identify a lead prototype. (Ethoxycarbonylmethyl-ethyl-phosphanyl)-acetic acid ethyl ester manufacturers “Alcami supported this product with supply constraints and successfully developed a capsule formulation for two dosage strengths,” she explains. “The formulations group performed studies at a micro-laboratory scale using a scientifically-based approach to identify a lead prototype. diethyl-{2-[3-(4-nitro-phenyl)-[1,2,4]oxadiazol-5-yl]-ethyl}-amine suppliers As the Covid-19 pandemic continues to challenge the global drug supply chain, nations are looking for new ways to enable native producers to continue scaling up. Now, an Israeli API maker is dropping a down payment into an Indian intermediates company to ramp up its own manufacturing base. Oxidase, cytochrome (Apis dorsata mitochondria-encoded gene COIsubunit I fragment) vendor & factory Zynteglo was granted conditional marketing authorisation in May 2019. The conditional authorisation means that there is more evidence to come about the medicine, which the company will provide. EMA regularly reviews new information that becomes available.,The Institute for Clinical and Economic Review (ICER) on Friday released its report examining the cost-effectiveness of Soliris, also known as eculizumab, as well as up-and-comer efgartigimod for patients with the myasthenia gravis.
